Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 study examining donor stem cell transplant for high-risk acute myeloid leukemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: University of Southern California | Conditions: Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a) | Phase 1 | Status: TERMINATED